We are pleased to see the UK Government has launched a joint public-private investment programme worth up to £400 million, which is set to boost UK clinical trials.

This aims to provide NHS patients with earlier access to new treatments and help the UK become the home of cutting-edge health research.

BIVDA's Policy and Public Affairs Executive Ben Kemp commented, “The declining number of clinical trials in the UK has greatly impeded patient access to pioneering therapies and technologies and has harmed UK industry.

"This announcement will help to address some of the long-standing issues and bolster the UK life sciences ecosystem.”